{"entity":{"type":"insider","cik":"0001778279","url":"/insider/0001778279","json_url":"/insider/0001778279.json","name":"Hill Emily Luisa","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":23,"first":"2020-01-08","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Hill Emily Luisa","source":"filing","n_filings":23,"first_seen":"2020-01-08","last_seen":"2026-08-19"}],"transactions":[{"id":9298484,"accession":"0001104659-26-098868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-098868","line_url":"/filing/0001104659-26-098868#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9256.0,"shares_display":"9,256","price_per_share":14.28,"price_display":"14.28","price_state":"stated","total_value":132175.68,"total_display":"132,175.68","total_whole":"132,176","shares_owned_after":215852.0,"shares_owned_after_display":"215,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-19","scope":"insider"},{"id":9224053,"accession":"0001104659-26-095008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-095008","line_url":"/filing/0001104659-26-095008#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11448.0,"shares_display":"11,448","price_per_share":12.97,"price_display":"12.97","price_state":"stated","total_value":148480.56,"total_display":"148,480.56","total_whole":"148,481","shares_owned_after":225108.0,"shares_owned_after_display":"225,108","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":6056803,"accession":"0001104659-26-064517","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-064517","line_url":"/filing/0001104659-26-064517#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7812.0,"shares_display":"7,812","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":39684.96,"total_display":"39,684.96","total_whole":"39,685","shares_owned_after":236556.0,"shares_owned_after_display":"236,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-18","filed_date":"2026-05-20","scope":"insider"},{"id":4799731,"accession":"0001104659-25-080403","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-080403","line_url":"/filing/0001104659-25-080403#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9154.0,"shares_display":"9,154","price_per_share":5.37,"price_display":"5.37","price_state":"stated","total_value":49156.98,"total_display":"49,156.98","total_whole":"49,157","shares_owned_after":134368.0,"shares_owned_after_display":"134,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-19","scope":"insider"},{"id":4327012,"accession":"0001104659-25-052142","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-052142","line_url":"/filing/0001104659-25-052142#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2535.0,"shares_display":"2,535","price_per_share":8.05,"price_display":"8.05","price_state":"stated","total_value":20406.75,"total_display":"20,406.75","total_whole":"20,407","shares_owned_after":143522.0,"shares_owned_after_display":"143,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":2086055,"accession":"0001104659-24-090980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-090980","line_url":"/filing/0001104659-24-090980#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8938.0,"shares_display":"8,938","price_per_share":10.18,"price_display":"10.18","price_state":"stated","total_value":90988.84,"total_display":"90,988.84","total_whole":"90,989","shares_owned_after":101057.0,"shares_owned_after_display":"101,057","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-16","filed_date":"2024-08-19","scope":"insider"},{"id":7842515,"accession":"0001415889-23-005564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-005564","line_url":"/filing/0001415889-23-005564#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7363.0,"shares_display":"7,363","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":331335.0,"total_display":"331,335.00","total_whole":"331,335","shares_owned_after":38925.0,"shares_owned_after_display":"38,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-27","filed_date":"2023-03-29","scope":"insider"},{"id":8344115,"accession":"0001415889-23-001798","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-001798","line_url":"/filing/0001415889-23-001798#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":575.0,"shares_display":"575","price_per_share":45.628,"price_display":"45.63","price_state":"stated","total_value":26236.1,"total_display":"26,236.10","total_whole":"26,236","shares_owned_after":46288.0,"shares_owned_after_display":"46,288","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":8200670,"accession":"0001415889-23-001459","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-001459","line_url":"/filing/0001415889-23-001459#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":47.4513,"price_display":"47.45","price_state":"stated","total_value":10581.6399,"total_display":"10,581.64","total_whole":"10,582","shares_owned_after":46863.0,"shares_owned_after_display":"46,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-26","scope":"insider"},{"id":8637036,"accession":"0001415889-23-000880","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000880","line_url":"/filing/0001415889-23-000880#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":418.0,"shares_display":"418","price_per_share":44.3596,"price_display":"44.36","price_state":"stated","total_value":18542.3128,"total_display":"18,542.31","total_whole":"18,542","shares_owned_after":47086.0,"shares_owned_after_display":"47,086","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-11","filed_date":"2023-01-12","scope":"insider"},{"id":8637034,"accession":"0001415889-23-000880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-000880","line_url":"/filing/0001415889-23-000880#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":497.0,"shares_display":"497","price_per_share":42.9329,"price_display":"42.93","price_state":"stated","total_value":21337.6513,"total_display":"21,337.65","total_whole":"21,338","shares_owned_after":47504.0,"shares_owned_after_display":"47,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":8005672,"accession":"0001415889-23-000838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-000838","line_url":"/filing/0001415889-23-000838#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":758.0,"shares_display":"758","price_per_share":41.6562,"price_display":"41.66","price_state":"stated","total_value":31575.3996,"total_display":"31,575.40","total_whole":"31,575","shares_owned_after":48001.0,"shares_owned_after_display":"48,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6409447,"accession":"0001415889-22-003564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-003564","line_url":"/filing/0001415889-22-003564#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (CHIEF FINANCIAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF FINANCIAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF FINANCIAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7910.0,"shares_display":"7,910","price_per_share":37.778,"price_display":"37.78","price_state":"stated","total_value":298823.98,"total_display":"298,823.98","total_whole":"298,824","shares_owned_after":29259.0,"shares_owned_after_display":"29,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-31","filed_date":"2022-04-01","scope":"insider"},{"id":6422163,"accession":"0001179110-22-000837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-000837","line_url":"/filing/0001179110-22-000837#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":553.0,"shares_display":"553","price_per_share":40.002,"price_display":"40.00","price_state":"stated","total_value":22121.106,"total_display":"22,121.11","total_whole":"22,121","shares_owned_after":37169.0,"shares_owned_after_display":"37,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-03","scope":"insider"},{"id":6945658,"accession":"0001179110-22-000629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-000629","line_url":"/filing/0001179110-22-000629#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211.0,"shares_display":"211","price_per_share":39.314,"price_display":"39.31","price_state":"stated","total_value":8295.254,"total_display":"8,295.25","total_whole":"8,295","shares_owned_after":37722.0,"shares_owned_after_display":"37,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-25","filed_date":"2022-01-27","scope":"insider"},{"id":6563576,"accession":"0001179110-22-000398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-22-000398","line_url":"/filing/0001179110-22-000398#line-2","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":38.525,"price_display":"38.52","price_state":"stated","total_value":30820.0,"total_display":"30,820.00","total_whole":"30,820","shares_owned_after":22333.0,"shares_owned_after_display":"22,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-11","scope":"insider"},{"id":6975504,"accession":"0001179110-22-000303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-000303","line_url":"/filing/0001179110-22-000303#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173.0,"shares_display":"173","price_per_share":41.162,"price_display":"41.16","price_state":"stated","total_value":7121.026,"total_display":"7,121.03","total_whole":"7,121","shares_owned_after":23133.0,"shares_owned_after_display":"23,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-06","scope":"insider"},{"id":5470443,"accession":"0001179110-21-001105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-001105","line_url":"/filing/0001179110-21-001105#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":541.0,"shares_display":"541","price_per_share":56.956,"price_display":"56.96","price_state":"stated","total_value":30813.196,"total_display":"30,813.20","total_whole":"30,813","shares_owned_after":23306.0,"shares_owned_after_display":"23,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-02","scope":"insider"},{"id":4174184,"accession":"0001179110-21-000874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-000874","line_url":"/filing/0001179110-21-000874#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":275.0,"shares_display":"275","price_per_share":62.054,"price_display":"62.05","price_state":"stated","total_value":17064.85,"total_display":"17,064.85","total_whole":"17,065","shares_owned_after":23847.0,"shares_owned_after_display":"23,847","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-25","filed_date":"2021-01-27","scope":"insider"},{"id":4628297,"accession":"0001179110-21-000538","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-21-000538","line_url":"/filing/0001179110-21-000538","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26033.0,"shares_display":"26,033","price_per_share":69.75,"price_display":"69.75","price_state":"stated","total_value":1815801.75,"total_display":"1,815,801.75","total_whole":"1,815,802","shares_owned_after":24122.0,"shares_owned_after_display":"24,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider","n_lines":4},{"id":4780907,"accession":"0001179110-21-000415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-000415","line_url":"/filing/0001179110-21-000415","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":288.0,"shares_display":"288","price_per_share":62.37,"price_display":"62.37","price_state":"stated","total_value":17962.56,"total_display":"17,962.56","total_whole":"17,963","shares_owned_after":13322.0,"shares_owned_after_display":"13,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-07","scope":"insider","n_lines":2},{"id":2605237,"accession":"0001070081-20-000112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001070081-20-000112","line_url":"/filing/0001070081-20-000112#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2581.0,"shares_display":"2,581","price_per_share":52.5,"price_display":"52.50","price_state":"stated","total_value":135502.5,"total_display":"135,502.50","total_whole":"135,503","shares_owned_after":13610.0,"shares_owned_after_display":"13,610","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-29","filed_date":"2020-07-01","scope":"insider"},{"id":2389537,"accession":"0001070081-20-000024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001070081-20-000024","line_url":"/filing/0001070081-20-000024#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":330.0,"shares_display":"330","price_per_share":53.247,"price_display":"53.25","price_state":"stated","total_value":17571.51,"total_display":"17,571.51","total_whole":"17,572","shares_owned_after":6891.0,"shares_owned_after_display":"6,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-23","filed_date":"2020-01-27","scope":"insider"},{"id":3079334,"accession":"0001070081-20-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001070081-20-000010","line_url":"/filing/0001070081-20-000010#line-3","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63.0,"shares_display":"63","price_per_share":49.621,"price_display":"49.62","price_state":"stated","total_value":3126.123,"total_display":"3,126.12","total_whole":"3,126","shares_owned_after":7221.0,"shares_owned_after_display":"7,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-08","scope":"insider"},{"id":3079327,"accession":"0001070081-20-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001070081-20-000010","line_url":"/filing/0001070081-20-000010","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001778279","owner_name":"Hill Emily Luisa","owner_display_name":"Hill Emily Luisa","owner_url":"/insider/0001778279","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":321.0,"shares_display":"321","price_per_share":48.168,"price_display":"48.17","price_state":"stated","total_value":15461.928,"total_display":"15,461.93","total_whole":"15,462","shares_owned_after":7284.0,"shares_owned_after_display":"7,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-06","filed_date":"2020-01-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2024-08-19","last_seen":"2026-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Officer (CHIEF FINANCIAL OFFICER)","n_filings":17,"first_seen":"2020-01-08","last_seen":"2023-03-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001778279","retrieved_at":"2026-08-26T10:54:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}